Transdermal delivery of plasmid encoding truncated nucleocapsid protein enhanced PRRSV-specific immune responses

Vaccine

Volumn 34, Issue 5, 2016, Pages 609-615

  Suradhat, Sanipa ^a   Wongyanin, Piya ^a,c   Sirisereewan, Chaitawat ^a   Nedumpun, Teerawut ^a   Lumyai, Mongkol ^a,d   Triyarach, Sittikorn ^a,e   Chaturavittawong, Damnoen ^b   Paphavasit, Termsit ^b   Panyatong, Raphee ^b   Thanawongnuwech, Roongroje ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b Bangkok Agro Industrial Products Public CoLtd ^*  (Thailand)

^c BANSOMDEJCHAOPRAYA RAJABHAT UNIVERSITY   (Thailand)

^d Thai Denmark Swine Breeder Public Company Limited   (Thailand)

^e ZOETIS   (United States)

Author keywords

DNA vaccine; Needle free injection; Nucleocapsid protein; PRRSV; Transdermal; Tregs

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; DNA VACCINE; GAMMA INTERFERON; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 10; LIVE VACCINE; NUCLEOCAPSID PROTEIN; NUCLEOCAPSID PROTEIN PORF7T; UNCLASSIFIED DRUG; VIRUS VACCINE; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG EFFECT; EXPERIMENTAL PIG; FARM ANIMAL; IMMUNE RESPONSE; IMMUNOMODULATION; NONHUMAN; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMID; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; VACCINATION; VIRUS IMMUNITY; ANIMAL; BLOOD; CELLULAR IMMUNITY; CUTANEOUS DRUG ADMINISTRATION; IMMUNOLOGY; PIG; PROCEDURES; SECONDARY IMMUNIZATION; VETERINARY;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIBODIES, VIRAL; IMMUNITY, CELLULAR; IMMUNIZATION, SECONDARY; INTERFERON-GAMMA; INTERLEUKIN-10; NUCLEOCAPSID PROTEINS; PLASMIDS; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SUS SCROFA; SWINE; T-LYMPHOCYTES, REGULATORY; VACCINATION; VACCINES, ATTENUATED; VACCINES, DNA; VIRAL VACCINES;

EID: 84953791283     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.12.043     Document Type: Article

References (39)

1. Van Reeth K., Nauwynck H. Proinflammatory cytokines and viral respiratory disease in pigs. Vet Res 2000, 31:187-213.
2. Thanawongnuwech R., Brown G.B., Halbur P.G., Roth J.A., Royer R.L., Thacker B.J. Pathogenesis of porcine reproductive and respiratory syndrome virus-induced increase in susceptibility to Streptococcus suis infection. Vet Pathol 2000, 37:143-152.
3. Lopez O.J., Osorio F.A. Role of neutralizing antibodies in PRRSV protective immunity. Vet Immunol Immunopathol 2004, 102:155-163.
4. Mateu E., Diaz I. The challenge of PRRS immunology. Vet J 2008, 117:345-351.
5. Cecere T.E., Todd S.M., Leroith T. Regulatory T cells in arterivirus and coronavirus infections: do they protect against disease or enhance it?. Viruses 2012, 4:833-846.
6. Huang C., Zhang Q., Feng W.H. Regulation and evasion of antiviral immune responses by porcine reproductive and respiratory syndrome virus. Virus Res 2015, 202:101-111.
7. Meng X.J. Heterogeneity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficiency and future vaccine development. Vet Microbiol 2000, 74:309-329.
8. Meier W.A., Galeota J., Osorio F.A., Husmann R.J., Schnitzlein W.M., Zuckermann F.A. Gradual development of the interferon-gamma response of swine to porcine reproductive and respiratory syndrome virus infection or vaccination. Virology 2003, 309:18-31.
9. Suradhat S., Kesdangsakonwut S., Sada W., Buranapraditkun S., Wongsawang S., Thanawongnuwech R. Negative impact of porcine reproductive and respiratory syndrome virus infection on the efficacy of classical swine fever vaccine. Vaccine 2006, 24:2634-2642.
10. Song S., Bi J., Wang D., Fang L., Zhang L., Li F., et al. Porcine reproductive and respiratory syndrome virus infection activates IL-10 production through NF-kappaB and p38 MAPK pathways in porcine alveolar macrophages. Dev Comp Immunol 2013, 39:265-272.
11. Silva-Campa E., Mata-Haro V., Mateu E., Hernandez J. Porcine reproductive and respiratory syndrome virus induces CD4+CD8+CD25+Foxp3+ regulatory T cells (Tregs). Virology 2012, 430:73-80.
12. Nelson E.A., Christopher-Hennings J., Benfield D.A. Serum immune responses to the proteins of porcine reproductive and respiratory syndrome (PRRS) virus. J Vet Diagn Invest 1994, 6:410-415.
13. Dea S., Gagnon C.A., Mardassi H., Pirzadeh B., Rogan D. Current knowledge on the structural proteins of porcine reproductive and respiratory syndrome (PRRS) virus: comparison of the North American and European isolates. Arch Virol 2000, 145:659-688.
14. Snijder E.J., Kikkert M., Fang Y. Arterivirus molecular biology and pathogenesis. J Gen Virol 2013, 94:2141-2163.
15. Wongyanin P., Buranapraditkul S., Yoo D., Thanawongnuwech R., Roth J.A., Suradhat S. Role of porcine reproductive and respiratory syndrome virus nucleocapsid protein in induction of interleukin-10 and regulatory T-lymphocytes (Treg). J Gen Virol 2012, 93:1236-1246.
16. Liu X., Fan B., Bai J., Wang H., Li Y., Jiang P. The N-N non-covalent domain of the nucleocapsid protein of type 2 porcine reproductive and respiratory syndrome virus enhances induction of IL-10 expression. J Gen Virol 2015, 96:1276-1286.
17. Diaz I., Pujols J., Ganges L., Gimeno M., Darwich L., Domingo M., et al. In silico prediction and ex vivo evaluation of potential T-cell epitopes in glycoproteins 4 and 5 and nucleocapsid protein of genotype-I (European) of porcine reproductive and respiratory syndrome virus. Vaccine 2009, 27:5603-5611.
18. Cancel-Tirado S.M., Evans R.B., Yoon K.J. Monoclonal antibody analysis of porcine reproductive and respiratory syndrome virus epitopes associated with antibody-dependent enhancement and neutralization of virus infection. Vet Immunol Immunopathol 2004, 102:249-262.
19. Thanawongnuwech R., Suradhat S., Taming P.R.R.S.V. Revisiting the control strategies and vaccine design. Virus Res 2010, 154:133-140.
20. Suradhat S., Wongyanin P., Kesdangsakonwut S., Teankum K., Lumyai M., Triyarach S., et al. A novel DNA vaccine for reduction of PRRSV-induced negative immunomodulatory effects: a proof of concept. Vaccine 2015, 33:3997-4003.
21. Houser T.A., Sebranek J.G., Thacker B.J., Baas T.J., Nilubol D., Thacker E.L., et al. Effectiveness of transdermal, needle-free injections for reducing pork carcass defects. Meat Sci 2004, 68:329-332.
22. van Drunen Littel-van den Hurk S., Babiuk S., Babiuk L.A. Needle-free delivery of veterinary DNA vaccines. Methods Mol Med 2006, 127:91-105.
23. Martelli P., Cordioli P., Alborali L.G., Gozio S., De Angelis E., Ferrari L., et al. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain. Vaccine 2007, 25:3400-3408.
24. Chase C.C.L., Daniels S., Garcia R., Milward F., Nation T. Needle-free injection technology in swine: progress toward vaccine efficacy and pork quality. J Swine Health Prod 2008, 16:254-261.
25. Martelli P., Gozio S., Ferrari L., Rosina S., De Angelis E., Quintavalla C., et al. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: clinical protection and cell-mediated immunity. Vaccine 2009, 27:3788-3799.
26. Gorres J.P., Lager K.M., Kong W.P., Royals M., Todd J.P., Vincent A.L., et al. DNA vaccination elicits protective immune responses against pandemic and classic swine influenza viruses in pigs. Clin Vaccine Immunol 2011, 18:1987-1995.
27. Goubier A., Fuhrmann L., Forest L., Cachet N., Evrad-Blanchard M., Juillard V., et al. Superiority of needle-free transdermal plasmid delivery for the induction of antigen-specific IFNgamma T cell responses in the dog. Vaccine 2008, 26:2186-2190.
28. Thanawongnuwech R., Amonsin A., Tasanakit A., Damrongwatanapokin S. Genetics and geographical variation of porcine reproductive and respiratory syndrome virus (PRRSV) in Thailand. Vet Microbiol 2004, 101:9-21.
29. Thanawongnuwech R., Halbur P.G., Ackermann M.R., Thacker E.L., Royer R.L. Effects of low (modified-live virus vaccine) and high (VR-2385) virulence strains of porcine reproductive and respiratory syndrome virus (PRRSV) on pulmonary clearance of copper particles in pigs. Vet Pathol 1998, 35:398-406.
30. Halbur P.G., Paul P.S., Frey M.L., Landgraf J., Eernisse K., Meng X.J., et al. Comparison of the pathogenicity of two US porcine reproductive and respiratory syndrome virus isolates with that of the Lelystad virus. Vet Pathol 1995, 32(6):648-660.
31. Marquet F., Bonneau M., Pascale F., Urien C., Kang C., Schwartz-Cornil I., et al. Characterization of dendritic cells subpopulations in skin and afferent lymph in the swine model. PLoS One 2011, 6:e16320.
32. Summerfield A., Meurens F., Ricklin M.E. The immunology of the porcine skin and its value as a model for human skin. Mol Immunol 2015, 66:14-21.
33. Levine M.M., Sztein M.B. Vaccine development strategies for improving immunization: the role of modern immunology. Nat Immunol 2004, 5:460-464.
34. Wang Y., Zhao H., Ma Z., Feng W.H. CTLA4 mediated targeting enhances immunogenicity against PRRSV in a DNA prime/killed virus boost strategy. Vet Immunol Immunopathol 2013, 154:121-128.
35. Charerntantanakul W. Porcine reproductive and respiratory syndrome virus vaccines: Immunogenicity, efficacy and safety aspects. World J Virol 2012, 1:23-30.
36. Hu J., Zhang C. Porcine reproductive and respiratory syndrome virus vaccines: current status and strategies to a universal vaccine. Transbound Emerg Dis 2014, 61:109-120.
37. Charerntantanakul W., Kasinrerk W. Interleukin-10 antisense oligodeoxynucleotide suppresses IL-10 expression and effects on proinflammatory cytokine responses to porcine reproductive and respiratory syndrome virus. Viral Immunol 2010, 23:425-435.
38. Charerntantanakul W., Platt R., Roth J.A. Effects of porcine reproductive and respiratory syndrome virus-induced antigen-presenting cells on T cell activation and anti-viral cytokine production. Viral Immunol 2006, 19:646-661.
39. LeRoith T., Hammond S., Todd S.M., Ni Y., Cecere T., Pelzer K.D. A modified live PRRSV vaccine and the pathogenic parent strain induce regulatory T cells in pigs naturally infected with Mycoplasma hyopneumoniae. Vet Immunol Immunopathol 2011, 140:312-316.